Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.

Key PointsThe drug could eventually generate more than $1 billion annually.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Health & Medicine

More from Saturday 3 October →